封面
市場調查報告書
商品編碼
1487680

口腔睡眠呼吸中止裝置市場規模 - 按裝置類型(下顎前移裝置、舌頭固定裝置、快速上顎擴張)、按適應症、按購買類型、按性別、按最終用途、按配銷通路和預測,2024 - 2032年

Oral Sleep Apnea Devices Market Size - By Device Type (Mandibular Advancement Devices, Tongue-retaining Devices, Rapid Maxillary Expansion), By Indication, By Purchase Type, By Gender, By End-use, By Distribution Channel & Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 220 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於全球睡眠呼吸中止症盛行率不斷上升,預計 2024 年至 2032 年間,口腔睡眠呼吸中止症設備市場規模將以 10.7% 的複合年成長率成長。根據美國國家健康研究所的數據,睡眠呼吸中止症影響著9.36 億30 歲至69 歲的成年人。人員正在積極尋求替代解決方案。為此,口腔睡眠呼吸中止裝置提供非侵入性且對患者友善的治療選擇,已獲得了巨大的關注。

隨著家庭和微創治療的日益受到重視,口腔睡眠呼吸中止症裝置為傳統療法(例如持續性呼吸道正壓通氣 (CPAP) 機)提供了一種方便且經濟高效的替代方案。製造商和醫療保健提供者之間的合作,以及有利於口腔矯正器治療的報銷政策,以促進更大的市場滲透,將促進市場成長。

口腔睡眠呼吸中止症裝置產業分為裝置類型、適應症、購買類型、性別、最終用途、配銷通路和地區。

根據設備類型,到2032 年,快速上顎擴張細分市場的市場價值預計將達到10.6% 的複合年成長率。在治療阻塞性牙齒矯正方面的潛力而獲得認可。透過加寬上顎並增加呼吸道尺寸,快速上顎擴張裝置可以減輕睡眠期間的呼吸道阻塞,從而改善呼吸並減少呼吸中止發作。

在配銷通路方面,口腔睡眠呼吸中止設備市場的醫院藥房部分從2024年到2032年將錄得10.1%的成長率。主要中心。隨著人們對 OSA 及其潛在健康後果的認知不斷提高,醫院藥局正在積極尋求有效的治療方案來滿足患者的需求。此外,醫院還與醫療設備製造商和供應商建立了關係,以方便取得產品。

亞太地區口腔睡眠呼吸中止裝置產業在 2024 年至 2032 年間將以 11.9% 的複合年成長率成長,原因是睡眠呼吸中止症疾病的盛行率不斷上升,以及人們對其健康影響的認知不斷提高。快速擴張的醫療基礎設施和不斷成長的可支配收入水準正在促進更多人獲得口腔睡眠呼吸中止症裝置。旨在促進睡眠健康和改善醫療服務可近性的政府措施正在促進整個地區的產品需求。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 睡眠呼吸中止症及相關併發症的盛行率不斷上升
      • 技術進步
      • 人們對睡眠呼吸中止症和其他睡眠障礙的認知不斷提高
      • 對口腔睡眠呼吸中止裝置的需求不斷成長
    • 產業陷阱與挑戰
      • 嚴格規定
      • 缺乏對睡眠呼吸中止症治療的依從性
  • 成長潛力分析
  • 波特的分析
  • PESTEL分析
  • 未來市場趨勢
  • 報銷場景
  • 監管環境
  • 技術景觀
  • 缺口分析

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按設備類型,2018 年 - 2032 年

  • 主要趨勢
  • 下顎前移裝置
  • 舌頭固定裝置
  • 上顎快速擴張
  • 護齒套

第 6 章:市場估計與預測:按指標分類,2018 年 - 2032 年

  • 主要趨勢
  • 輕度睡眠呼吸中止症
  • 中度睡眠呼吸暫停
  • 嚴重睡眠呼吸中止症

第 7 章:市場估計與預測:按購買類型,2018 年 - 2032 年

  • 主要趨勢
  • 醫生處方/客製化口腔裝置
  • 非處方口腔器械

第 8 章:市場估計與預測:按性別分類,2018 年 - 2032 年

  • 主要趨勢
  • 男性
  • 女性

第 9 章:市場估計與預測:按最終用途,2018 - 2032 年

  • 主要趨勢
  • 家庭護理設置
  • 睡眠實驗室和醫院
  • 牙醫診所

第 10 章:市場估計與預測:按配銷通路分類,2018 年 - 2032 年

  • 主要趨勢
  • 磚塊和灰漿
  • 電子商務
  • 醫院藥房

第 11 章:市場估計與預測:按地區分類,2018 年 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 12 章:公司簡介

  • Apnea Sciences
  • DynaFlex
  • Glidewell
  • MPowrx Health & Wellness
  • Myerson LLC
  • OravanOSA
  • Panthera Dental
  • ProSomnus Sleep Technologies
  • PureSleep
  • ResMed
  • SomnoMed
  • Vivos Therapeutics, Inc.
簡介目錄
Product Code: 8530

Oral sleep apnea devices market size is anticipated to grow at 10.7% CAGR between 2024 and 2032, driven by the rising prevalence of sleep apnea globally. As per Nation Institute of Health, sleep apnea impacts 936 million adults between the ages of 30 and 69. As awareness about the adverse health effects of untreated sleep apnea is increasing, individuals and healthcare professionals are actively seeking alternative solutions. To that end, oral sleep apnea devices, which offer non-invasive and patient-friendly treatment options, have gained significant traction.

With growing emphasis on home-based and minimally invasive treatments, oral sleep apnea devices provide a convenient and cost-effective alternative to traditional therapies, such as continuous positive airway pressure (CPAP) machines. Collaborations between manufacturers and healthcare providers, along with reimbursement policies favoring oral appliance therapy to facilitate greater market penetration will add to the market growth.

The oral sleep apnea devices industry is classified into device type, indication, purchase type, gender, end use, distribution channel and region.

Based on device type, the market value from the rapid maxillary expansion segment is anticipated to witness 10.6% CAGR through 2032. This orthodontic technique, primarily used to address issues related to malocclusion and narrow dental arches, has gained recognition for its potential in treating obstructive sleep apnea (OSA). By widening the upper jaw and increasing airway dimensions, rapid maxillary expansion devices can alleviate airway obstruction during sleep for improving breathing and reducing apnea episodes.

In terms of distribution channel, the hospital pharmacies segment in the oral sleep apnea devices market will record 10.1% growth rate from 2024 to 2032. Hospital pharmacies are the primary centers for diagnosing and treating sleep disorders, including obstructive sleep apnea (OSA). As awareness about OSA and its potential health consequences is increasing, hospital pharmacies are actively seeking effective treatment options to meet patient needs. Additionally, hospitals have established relationships with medical device manufacturers and suppliers for facilitating easier access to the product.

Asia Pacific oral sleep apnea devices industry will grow at 11.9% CAGR between 2024 and 2032, attributed to the increasing prevalence of sleep apnea disorders, coupled with rising awareness about its health implications. The rapidly expanding healthcare infrastructure and growing disposable income levels are facilitating greater access to oral sleep apnea devices. Favorable government initiatives aimed at promoting sleep health and improving access to healthcare services are contributing to the product demand across the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of sleep apnea and related co-morbidities
      • 3.2.1.2 Technological advancements
      • 3.2.1.3 Surging awareness regarding sleep apnea and other sleep disorders
      • 3.2.1.4 Rising demand for oral sleep apnea devices
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Stringent regulations
      • 3.2.2.2 Lack of adherence to sleep apnea treatment
  • 3.3 Growth potential analysis
  • 3.4 Porter's analysis
    • 3.4.1 Supplier power
    • 3.4.2 Buyer power
    • 3.4.3 Threat of new entrants
    • 3.4.4 Threat of substitutes
    • 3.4.5 Industry rivalry
  • 3.5 PESTEL analysis
  • 3.6 Future market trends
  • 3.7 Reimbursement scenario
  • 3.8 Regulatory landscape
  • 3.9 Technological landscape
  • 3.10 GAP analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Mandibular advancement devices
  • 5.3 Tongue-retaining devices
  • 5.4 Rapid maxillary expansion
  • 5.5 Mouth guards

Chapter 6 Market Estimates and Forecast, By Indication, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Mild sleep apnea
  • 6.3 Moderate sleep apnea
  • 6.4 Severe sleep apnea

Chapter 7 Market Estimates and Forecast, By Purchase Type, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Physician-prescribed/customized oral devices
  • 7.3 OTC oral devices

Chapter 8 Market Estimates and Forecast, By Gender, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Male
  • 8.3 Female

Chapter 9 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Homecare settings
  • 9.3 Sleep laboratories & hospitals
  • 9.4 Dental clinics

Chapter 10 Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 ($ Mn)

  • 10.1 Key trends
  • 10.2 Brick and mortar
  • 10.3 E-commerce
  • 10.4 Hospital pharmacies

Chapter 11 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 11.1 Key trends
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 France
    • 11.3.4 Italy
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 South Korea
    • 11.4.6 Rest of Asia Pacific
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Argentina
    • 11.5.4 Rest of Latin America
  • 11.6 Middle East and Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 South Africa
    • 11.6.3 UAE
    • 11.6.4 Rest of Middle East and Africa

Chapter 12 Company Profiles

  • 12.1 Apnea Sciences
  • 12.2 DynaFlex
  • 12.3 Glidewell
  • 12.4 MPowrx Health & Wellness
  • 12.5 Myerson LLC
  • 12.6 OravanOSA
  • 12.7 Panthera Dental
  • 12.8 ProSomnus Sleep Technologies
  • 12.9 PureSleep
  • 12.10 ResMed
  • 12.11 SomnoMed
  • 12.12 Vivos Therapeutics, Inc.